期刊文献+

脑电图在路易体痴呆和阿尔茨海默病鉴别中作用的研究

The EEG as a diagnostic tool in distinguishing between dementia with Lewy bodies and Alzheimer's disease
下载PDF
导出
摘要 目的此研究的目的是探讨总计脑电图(GTE)得分用于区别诊断路易体痴呆(DLB)和阿尔茨海默病(AD)的作用。方法根据GTE得分对30例DLB患者和52例AD患者的脑电图(EEG)进行了直观的评估。结果 DLB患者平均得分显著高于AD患者,得分比为9:4.DLB患者以6.5的GTE截止得分区别于AD患者,其灵敏度为80%,特异性为78%。GTE和DLB之间的关联独立于年龄、性别、简易精神状态检查和药物使用。额叶间歇节奏增量活性(FIRDA)在DLB患者和AD患者中分别为16.7%、1.9%。结论 EEG作为日常临床实践中区分DLB和AD的诊断工具应该发挥更加突出的作用。GTE得分法已被证明是适用于日常临床实践的可靠简单的评分法。定性EEG分析对于区别诊断DLB和AD帮助较大,并且有较高的灵敏度和特异性。 Objective To explore the effect of EEG total score(GTE) in differential diagnosis of dementia with Lemy bodies(DLE)and Alzheimer's disease(AD). Method EEGs from 30 patients with DLB and 52 with AD were visually rated according to the GTE score. Results Patients with DLB had significantly higher median scores than patients with AD: 9 vs 4. Patients with DLB could be distinguished from those with AD at a GTE cut-off score of 6.5 with a sensitivity of 80% and a specificity of 78%. The association between GTE and DLB was independent of age, gender, Mini Mental State Examination and use of medication. Frontal intermittent rhythmic delta activity (FIRDA)was found in 16.7% of patients with DLB compared to 1.9% with AD. Conclusion The GTE score has proven to be a reliable and simple scoring method applicable to daily clinical practice. Qualitative EEG analysis can help to differentiate DLB from AD with good sensitivity and specificity.
出处 《脑与神经疾病杂志》 2016年第11期689-693,共5页 Journal of Brain and Nervous Diseases
基金 陕西省科技统筹创新工程计划项目(2013KTCQ03-08)
关键词 路易体痴呆 阿尔茨海默病 脑电图 痴呆 临床神经生理学 Dementia with Lewy bodies Alzheimer's disease Electroencephalogram Dementia Clinical neurophysiology
  • 相关文献

参考文献9

二级参考文献147

  • 1Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease [J]. Mov Disord, 2007,22(12) :1689-707.
  • 2Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers[J]. Neurology, 2007,68(11):812-819.
  • 3Aarsland D, Rongve A, Piepenstock N, et al. Frequency and case identification of dementia with I.ewy bodies using the re vised consensus criteria [J]. Dement Geriatr Cogn Disord, 2008, 26(5):455-52.
  • 4Johansen KK, White LR, Sando SB, et al. Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies [J]. ParkinsonismRelat Disord, 2010,16(5):307 15.
  • 5Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mu ration, E46K, of alpha-synuclein causes Parkinson and Lewy bodydementia[J]. AnnNeurol, 2004, 55 :164-173.
  • 6Lane R, He Y, Morris C, el al. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline [J]. Mov Disord, 2009, 24(3) :392-400.
  • 7Gatt AP, Jones EI., Francis PT, et al. Association of a poly morphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewybodies[J]. NeurosciLett, 2013,557:177-80.
  • 8Piggott MA, Marshall EF, Thomas N, et al. Striatal dopam inergic markers in dementia with I.ewy bodies Alzheimer and Parkinson disease rostrocaudal distribution[J]. Brain, 1999, 122:1449-1468.
  • 9Aarsland D, Ballard CG, Halliday G, et al. Are Parkinson's Disease with dementia and Dementia with lewy Bodies the Same Entity[J]. J Geriatr Psychiatry Neurol, 2004, 17(3):137-45.
  • 10Lee JE, Park B, Song SK, et al. A comparison of gray and white matter density in patients with Parkinson's disease de mentia and dementia with Lewy bodies using voxel-based morphometry[J]. Movement Disorders 25, 2010, 25 ( 1 ):28-34.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部